{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:15:31Z","timestamp":1790187331677,"version":"4.1.0"},"reference-count":27,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clin Med Insights Oncol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This present study aimed to evaluate the efficacy, safety, and prognostic factors of pembrolizumab in Vietnamese patients with platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma (R\/M HNSCC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a multicenter retrospective cohort study of 62 patients with platinum-refractory recurrent or metastatic HNSCC who received pembrolizumab monotherapy (200 mg every 3 weeks) from January 2020 to June 2024 at Vietnam National Cancer Hospital \u2013 K Hospital and Hanoi Oncology Hospital. The primary endpoint was overall survival (OS); secondary endpoints included progression-free survival (PFS), overall response rate (ORR) per RECIST v1.1, and safety per CTCAE v5.0. Survival was assessed using Kaplan-Meier methods, and prognostic factors were evaluated with multivariable Cox regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 62 patients (85.5% male, mean age 58.9\u00b19.7 years), the ORR and disease control rate were 25.8% and 51.6%, respectively. Median PFS was 4.3 months (95% confidence interval [CI] 2.9-5.7), and median OS was 7.5 months (95% CI 5.9-9.1). Programmed death-ligand 1 (PD-L1) combined positive score (CPS) \u226520 was associated with improved PFS (hazard ratio [HR] 0.452, 95% CI, 0.245-0.832, P=0.005) and OS (HR 0.373, 95% CI 0.157-0.884, P=0.025). Pembrolizumab monotherapy was well-tolerated with grade 3-4 adverse events in 3.2% of patients and lack of treatment-related deaths.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This real-world study confirms that pembrolizumab monotherapy provides clinically meaningful efficacy and favorable safety in later-line Vietnamese R\/M HNSCC patients, with enhanced benefit in PD-L1 CPS\u226520, supporting its role in resource-limited settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/11795549261468467","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T06:56:08Z","timestamp":1783752968000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of Pembrolizumab as a Second- or Third-Line Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Multicenter Retrospective Study in Vietnamese Patients"],"prefix":"10.1177","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0249-3167","authenticated-orcid":false,"given":"Phuong Thi Bich","family":"Nguyen","sequence":"first","affiliation":[{"name":"Hanoi Medical University"},{"name":"Vietnam National Cancer Hospital \u2013 K Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hau Xuan","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Hanoi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gia Hoang","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Hanoi Oncology Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1363-8161","authenticated-orcid":false,"given":"Tai Nguyen","family":"Van","sequence":"additional","affiliation":[{"name":"Vietnam National Cancer Hospital \u2013 K Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kien Do","family":"Hung","sequence":"additional","affiliation":[{"name":"Hanoi Medical University"},{"name":"Vietnam National Cancer Hospital \u2013 K Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/medsci11020042"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109282"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00224-3"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/lary.32450"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802656"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)31999-8"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(16)30066-3"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2016.70.1524"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13480"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1360657"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07214-4"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000009519"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.008"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0131-9"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)32591-7"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp-2023-209059"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/11795549241290030"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-SITC2022.0433"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-018-1241-1"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103961"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1715715"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0326177"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0662-5"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.15948"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.76709"}],"container-title":["Clinical Medicine Insights: Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11795549261468467","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/11795549261468467","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11795549261468467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:17:48Z","timestamp":1783927068000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/11795549261468467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":27,"alternative-id":["10.1177\/11795549261468467"],"URL":"https:\/\/doi.org\/10.1177\/11795549261468467","relation":{},"ISSN":["1179-5549","1179-5549"],"issn-type":[{"value":"1179-5549","type":"print"},{"value":"1179-5549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"article-number":"11795549261468467"}}